Industry News

Aug 27, 2018
By BioPharm International Editors
The Coalition for Epidemic Preparedness Innovations (CEPI) and vaccine manufacturer IDT Biologika will collaborate to develop and manufacture a vaccine against Middle East Respiratory Syndrome Coronavirus (MERS-CoV).
Aug 24, 2018
By BioPharm International Editors
FDA sent a warning letter to Kyowa Hakko Bio Co., Ltd. after inspectors found data integrity problems at the company’s Yamaguchi, Japan facility.
Aug 24, 2018
By BioPharm International Editors
The new Testa Center in Uppsala, Sweden is a collaborative test bed offering biotechnology equipment from GE Healthcare for process development.
Aug 23, 2018
By BioPharm International Editors
As a contingency against border delays resulting from a “no-deal” Brexit, the Department of Health and Social Care (DHSC) directs pharma companies to stock extra medicines.
Aug 23, 2018
By BioPharm International Editors
Guidances for regulatory changes, batch testing, and reporting address situations resulting from “no-deal” Brexit scenario.
Aug 21, 2018
By BioPharm International Editors
Experts from the Partnership for Research on Ebola VACcination report on progress and uncertainties regarding a safe and effective Ebola vaccine.
Aug 20, 2018
By BioPharm International Editors
The National Institute of Allergy and Infectious Diseases began a first-in-human trial of an experimental live, attenuated Zika virus vaccine.
Aug 17, 2018
By BioPharm International Editors
FDA approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector.
Aug 16, 2018
By BioPharm International Editors
FDA sent a warning letter to Apotex Research Private Limited after investigators found current good manufacturing practice violations.
Aug 16, 2018
By BioPharm International Editors
FDA grants support US research in continuous manufacturing monitoring and control techniques for bio/pharmaceutical manufacturing at Rutgers, MIT, and Georgia Tech.
native1_300x100
lorem ipsum